Our Services
Medical Information
Helpful Resources
Published on: 10/9/2026
Purpura is a rash of flat purple, red, or brown spots that forms when blood leaks out of damaged or broken blood vessels into the skin, and it does not fade or blanch when pressed because that blood now sits in the surrounding tissue instead of inside intact vessels. Causes range from minor trauma, fragile aging skin, and certain medications to low platelet counts, clotting disorders, vasculitis, and serious infections such as meningococcal disease. Spot size, location, and accompanying signs like fever, bleeding gums, or feeling generally unwell all change how urgent the situation is, so there are several important factors to consider before assuming a non-blanching rash is harmless. The full explanation below covers the warning signs that call for same-day care.
Because a rash that stays put under pressure can signal anything from a benign bruise to a medical emergency, it is worth getting a clearer picture of your specific pattern of symptoms right now. Take a free, instant, online symptom check to understand what may be driving your rash and what the sensible next step is.
What Is a Purpura Rash?
A purpura rash appears as purple, red, or brown spots or patches on the skin. Unlike a typical bruise, purpura spots do not fade or turn white when you press on them. This non-blanching feature helps doctors distinguish purpura from other types of rashes.
Why Doesn’t a Purpura Rash Fade When Pressed?
When you press on normal skin or a red rash, the pressure temporarily pushes blood out of the tiny skin vessels (capillaries), causing the area to blanch (turn white). In purpura:
This non-blanching quality is a hallmark of purpura rash.
Purpura results from bleeding into the skin. The underlying reasons can include:
• Vessel fragility
– Age-related changes or certain medications (e.g., corticosteroids) can weaken vessel walls.
– Connective tissue disorders (e.g., Ehlers-Danlos syndrome) also make vessels more fragile.
• Platelet problems
– Low platelet count (thrombocytopenia) means not enough “platelet plugs” form to stop tiny bleeds.
– Platelet function disorders (e.g., immune thrombocytopenia) impair clot formation.
• Clotting factor deficiencies
– Hemophilia or vitamin K deficiency impairs the blood’s ability to clot normally.
– Liver disease can reduce production of clotting factors.
• Vessel inflammation (vasculitis)
– Infections, autoimmune conditions (e.g., Henoch-Schönlein purpura), or medications trigger inflammation in vessel walls, leading to leakage.
Medical professionals often classify purpura by size:
Understanding the size helps guide further evaluation and management.
Purpura can arise in a wide range of settings:
Medication-Induced
• Anticoagulants (e.g., warfarin, heparin)
• Antiplatelet drugs (e.g., aspirin, clopidogrel)
• Certain antibiotics or chemotherapies
Infections
• Viral (e.g., dengue fever, infectious mononucleosis)
• Bacterial (e.g., meningococcemia, sepsis)
• Rickettsial diseases (e.g., Rocky Mountain spotted fever)
Hematologic Disorders
• Immune thrombocytopenia (ITP)
• Thrombotic thrombocytopenic purpura (TTP)
• Leukemia or other bone marrow diseases
Systemic Conditions
• Vasculitis (e.g., Henoch-Schönlein purpura)
• Liver cirrhosis (affecting clotting factor production)
• Connective tissue diseases (e.g., systemic lupus erythematosus)
Nutritional Deficiencies
• Severe scurvy (vitamin C deficiency)
• Vitamin K deficiency
Many cases of purpura are harmless and resolve on their own or with simple treatment. However, you should seek medical attention if you notice:
In these situations, a purpura rash could signal a serious or life-threatening condition.
A healthcare provider will use the following steps:
History and Physical Exam
– Review any medications, recent infections, or family history.
– Check for signs of bleeding elsewhere (gums, urine, stool).
Laboratory Tests
– Complete blood count (CBC) to assess platelet count and hemoglobin.
– Coagulation studies (PT, aPTT) to evaluate clotting factors.
– Inflammatory markers if vasculitis is suspected.
Imaging or Biopsy
– Occasionally, a skin biopsy confirms vasculitis or vessel damage.
– Imaging (e.g., ultrasound, CT scan) if internal bleeding is a concern.
Treatment targets the underlying cause:
• Discontinuing or adjusting medications that increase bleeding risk
• Medications to boost platelets or clotting factors
– Steroids or IV immunoglobulin for immune-mediated thrombocytopenia
– Vitamin K supplementation if deficient
• Managing infections or systemic disease
– Antibiotics for bacterial causes
– Disease-specific therapy for autoimmune conditions
• Supportive care
– Rest, ice, and compression for large bruises
– Close monitoring in severe cases
Most mild purpura resolves within days to weeks once the trigger is addressed.
If your purpura rash is mild and you’re awaiting medical guidance:
If you’re unsure about the cause of your purpura rash, you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. This tool can help you weigh possible causes and decide how urgently to seek care.
free, online symptom check, using the doctor approved Ubie Symptom Checker
If you ever experience severe symptoms or signs of a serious bleed, please speak to a doctor right away.
(References)
* Gavura SR, Nusinowitz S. Leukocytoclastic vasculitis associated with clarithromycin. Ann Pharmacother. 1998 May;32(5):543-5. doi: 10.1345/aph.17286. PMID: 9606474.
* Rudd M, Eversole R, Carpenter W. Diascopy: a clinical technique for the diagnosis of vascular lesions. Gen Dent. 2001 Mar-Apr;49(2):206-9. PMID: 12004702.
* Yung AP, McDonald MI. Early clinical clues to meningococcaemia. Med J Aust. 2003 Feb 3;178(3):134-7. doi: 10.5694/j.1326-5377.2003.tb05106.x. PMID: 12558487.
* Murthy MB, Murthy B. Amlodipine-induced petechial rash. J Postgrad Med. 2011 Oct-Dec;57(4):341-2. doi: 10.4103/0022-3859.90091. PMID: 22120868.
* Honarpisheh H, Camp R, Lazova R. Staphylococcal Purpura Fulminans: Report of a Case. Am J Dermatopathol. 2015 Aug;37(8):643-6. doi: 10.1097/DAD.0000000000000175. PMID: 25099358.
* Speirs L, McVea S, Little R, Bourke T. What is that rash? Arch Dis Child Educ Pract Ed. 2018 Feb;103(1):25-26. doi: 10.1136/archdischild-2016-311782. Epub 2016 Oct 31. PMID: 27799151.
* Milani GP, Lava SAG, Ramelli V, Bianchetti MG. Prevalence and Characteristics of Nonblanching, Palpable Skin Lesions With a Linear Pattern in Children With Henoch-Schönlein Syndrome. JAMA Dermatol. 2017 Nov 1;153(11):1170-1173. doi: 10.1001/jamadermatol.2017.2105. PMID: 28678983; PMCID: PMC5817480.
* McGrath A, Barrett MJ. Petechiae. 2023 Jan. PMID: 29493956.
* Rigamonti E, Bedussi F, Blanc J, Gianella P, Vanini G. The Dark Purple Side of Ceftriaxone: A Case Report on Leucocytoclastic Vasculitis. Eur J Case Rep Intern Med. 2020;7(4):001464. doi: 10.12890/2020_001464. Epub 2020 Mar 5. PMID: 32309253; PMCID: PMC7162562.
* Almeida MS, Ramalho C, Gomes F, Ginga MDR, Vilchez J. Propylthiouracil-Induced Skin Vasculitis. Cureus. 2022 Jul;14(7):e27073. doi: 10.7759/cureus.27073. Epub 2022 Jul 20. PMID: 36000132; PMCID: PMC9390865.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.